Atlas Trials

A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Clinical trial NCT03851640 · RECRUITING

Trial details

NCT number
NCT03851640
Sponsor
Hinova Pharmaceuticals Inc.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
MCRPC
Start date
2019-04-12
Primary completion
2025-09-01
Enrollment
417

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.